Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Impax Asset Management Group plc boosted its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 21.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 140,000 shares of the health services provider’s stock after acquiring an […]
StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report report published on Saturday morning. The brokerage issued a buy rating on the health services provider’s stock. Several other equities research analysts have also recently commented on AMED. Cantor Fitzgerald raised their target price on Amedisys from $91.00 to $100.00 […]
Boston Partners boosted its stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 32.3% in the first quarter, HoldingsChannel reports. The firm owned 429,239 shares of the health services provider’s stock after buying an additional 104,737 shares during the period. Boston Partners’ holdings in Amedisys were worth $31,993,000 as of its most recent SEC filing. […]
Amedisys, Inc. (NASDAQ:AMED – Get Free Report) has earned an average recommendation of “Hold” from the thirteen brokerages that are covering the company, MarketBeat.com reports. Ten analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokerages that have […]
Cambiar Investors LLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 5.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 89,982 shares of the health services provider’s stock after acquiring an additional 4,733 shares during the […]